Market Insights Health OTC Pharmaceuticals

Cold & Cough Remedies - South Africa

South Africa

In South Africa, the revenue in the Cold & Cough Remedies market market reached €202.20m in 2024.
It is projected to experience an annual growth rate of 4.48% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue in this market, amounting to €10,270.00m in 2024.
In terms of per capita revenue, in South Africa generates €3.31 per person in 2024.
South Africa's cold and cough remedies market is experiencing a surge in demand due to the country's high prevalence of respiratory infections and changing weather patterns.

Key regions: Australia, Japan, India, Brazil, Canada

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Cold & Cough Remedies market in South Africa has been experiencing significant growth in recent years.

Customer preferences: South African consumers have shown a strong preference for over-the-counter cold and cough remedies. This can be attributed to several factors, including the convenience and accessibility of these products. Many consumers prefer to self-medicate for minor cold and cough symptoms, rather than seeking medical advice. Additionally, the affordability of over-the-counter remedies makes them a popular choice among consumers who may not have access to healthcare services.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in South Africa is the increasing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as being more natural and less likely to have side effects. This trend is in line with global consumer preferences, as natural and herbal remedies are gaining popularity worldwide. Another trend in the market is the growing popularity of combination cold and cough remedies. These products offer a convenient solution for consumers who are looking for relief from multiple symptoms. Combination remedies often contain ingredients that target different symptoms, such as nasal congestion, cough, and sore throat. This trend reflects the demand for products that provide comprehensive relief from cold and cough symptoms.

Local special circumstances: The high prevalence of cold and cough infections in South Africa contributes to the growth of the Cold & Cough Remedies market. The country experiences a significant burden of respiratory infections, particularly during the winter months. This creates a strong demand for products that can provide relief from cold and cough symptoms. Additionally, the South African healthcare system faces challenges in terms of accessibility and affordability. Many consumers may not have access to healthcare services or may find them to be too expensive. As a result, over-the-counter cold and cough remedies are often the first line of defense for consumers seeking relief from symptoms.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in South Africa can be attributed to several macroeconomic factors. Firstly, the country has experienced steady economic growth in recent years, leading to increased disposable income among consumers. This has allowed consumers to spend more on healthcare products, including cold and cough remedies. Furthermore, the increasing urbanization in South Africa has led to lifestyle changes that may contribute to the spread of cold and cough infections. Urban areas often have higher population densities, which can facilitate the transmission of respiratory infections. This, in turn, drives the demand for cold and cough remedies. In conclusion, the Cold & Cough Remedies market in South Africa is developing due to customer preferences for over-the-counter remedies, the increasing demand for natural and combination remedies, the high prevalence of respiratory infections, and underlying macroeconomic factors such as economic growth and urbanization.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.